Holdings Inc. (“Company” or “Tevogen Bio”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing ...

At J.P. Morgan, most biopharma executives expressed a neutral stance on the incoming administration, but just days later, ...

Ascentage Pharma Group said its American depositary shares were slated to begin trading on the Nasdaq Global Market on Friday, with its initial public offering priced at $17.25 per ADS.

After revenue boomed for biopharma manufacturers during the COVID pandemic, sales have stagnated for several CDMO giants, ...

As the year gets underway, analysts and biotech executives highlight cell therapy’s pivot from oncology to autoimmune ...

Former Asda and Marks & Spencer boss Lord Stuart Ross has contributed the decline in the UK economy to remote working. | ITV National News ...

Viking Therapeutics, Inc. offers promising advances in obesity and liver diseases, despite a recent stock drop over GLP-1 market concerns. Click for my VKTX update.

We have regressed in this country in terms of working practices, productivity and in terms of the country’s wellbeing.' ...

Remote working policies were introduced by most companies during Covid-19 lockdowns, with office employees the most affected ...

The House Oversight Committee is asking "tech leaders who have spoken publicly about debanking to share their stories." ...

Shares of Upstream Bio, Inc. (NASDAQ:UPB – Get Free Report) fell 3.9% on Friday . The company traded as low as $10.46 and last traded at $10.36. 8,771 shares changed hands during mid-day trading, a ...

As inflation concerns faded, traders’ allocations to Bitcoin and other crypto funds surged ahead of Trump's inauguration.